Ludger Roedder
Presidente presso Adare Pharmaceuticals SAS
Profilo
Ludger Roedder is currently a member of the Council for Responsible Nutrition, a member of the American Feed Industry Association, and the President of Adare Pharmaceuticals SAS.
He was previously the Chief Business Officer at BRAIN Biotech AG.
Mr. Roedder holds a Master's in Business Administration from Fairleigh Dickinson University.
Posizioni attive di Ludger Roedder
Società | Posizione | Inizio |
---|---|---|
American Feed Industry Association | Corporate Officer/Principal | - |
Council for Responsible Nutrition | Corporate Officer/Principal | - |
Adare Pharmaceuticals SAS
Adare Pharmaceuticals SAS Pharmaceuticals: MajorHealth Technology Adare Pharmaceuticals SAS offers effective abuse deterrence testing services to help develop formulations that cannot be misused by consumers. The private company is based in Houdan, France. The French company is a technology-driven cdmo providing product development through commercial manufacturing expertise focused on oral dosage forms for the pharmaceutical industry. Adare's technologies provide oral dose forms with taste masking and a modified release profile, among other capabilities. It was founded in 2015, and the CEOs are Gilles Chauviere, Isabelle de Azevedo, Michael Ryan, and Thomas Sellig. | Presidente | 03/12/2021 |
Precedenti posizioni note di Ludger Roedder
Società | Posizione | Fine |
---|---|---|
BRAIN BIOTECH AG | Corporate Officer/Principal | 07/07/2020 |
Formazione di Ludger Roedder
Fairleigh Dickinson University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
BRAIN BIOTECH AG | Health Technology |
Aziende private | 3 |
---|---|
American Feed Industry Association | |
Council for Responsible Nutrition | |
Adare Pharmaceuticals SAS
Adare Pharmaceuticals SAS Pharmaceuticals: MajorHealth Technology Adare Pharmaceuticals SAS offers effective abuse deterrence testing services to help develop formulations that cannot be misused by consumers. The private company is based in Houdan, France. The French company is a technology-driven cdmo providing product development through commercial manufacturing expertise focused on oral dosage forms for the pharmaceutical industry. Adare's technologies provide oral dose forms with taste masking and a modified release profile, among other capabilities. It was founded in 2015, and the CEOs are Gilles Chauviere, Isabelle de Azevedo, Michael Ryan, and Thomas Sellig. | Health Technology |
- Borsa valori
- Insiders
- Ludger Roedder